Mark Neumann
CIK 1756211 · Chief Commercial Officer · last filed 2026-02-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
34
Lifetime Open-Market Net
-$20.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MANE | Chief Commercial Officer | — | $96.07 | — | $0 | 1 | 2026-02-05 |
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | EVP, Chief Commercial Officer | 0 | $131.87 | $0 | -$20.59M | 33 | 2025-04-02 |
Recent Filings · Page 2 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$796.4K | EDGAR |
| 2023-11-08 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | −15,639 | -$1.72M | EDGAR |
| 2023-08-09 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$2.22M | EDGAR |
| 2023-03-30 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Sell (S) | −15,604 | -$847.4K | EDGAR |
| 2023-03-13 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +11,744 | -$539.6K | EDGAR |
| 2023-03-08 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-03 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Sell (S) | −7,241 | -$362.1K | EDGAR |
| 2023-02-27 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +3,860 | -$190.6K | EDGAR |
| 2023-02-22 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | +7,241 | -$183.2K | EDGAR |
| 2022-04-08 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$4.46M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.